Tango Therapeutics Inc.

Tango Therapeutics Inc.

World Rank (Aug-2026)
3993
Market Cap (Aug-2026)
4.316 Billion USD
Market Cap (Mar-08-2026)
2.283 Billion USD
World Rank (Jan-05-2024)
8,692
Market Cap (Jan-05-2024)
0.981 Billion USD
World Rank (Jul-30-2023)
16,442
Market Cap (Jul-30-2023)
0.270 Billion USD
World Rank (Jan-07-2022)
10,643
Market Cap (Jan-07-2022)
0.799 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
TNGX
Employee Count
91
Employee Count as of Date
As on 2021
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
62 Million USD
Annual Operating Income in USD
-111 Million USD
Annual Net Income in USD
-102 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
399 Million USD
Total Liabilities in USD
53 Million USD
Total Equity in USD
346 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biotechnology
Company Website
TANGO THERAPEUTICS, INC.
Company Profile

Tango Therapeutics is a Biotechnology company with the genetic alterations that fuel cancer by inactivating tumour suppressor genes and helping cancer cells evade killing by the immune system. The headquarters is in USA.

IPO Year
2020
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share